Bioventus Inc. Class A Common Stock (BVS)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Bioventus Inc. Class A Common Stock (BVS) is listed on Nasdaq, where it has traded since February 11, 2021.
- Listed On
- Nasdaq
- Listed Since
- February 11, 2021
- Employees
- 950
- Market Cap
- $1.0B
About Bioventus Inc. Class A Common Stock
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 151 institutions reported holding BVS, with 53.8 million shares worth $509.1 million in aggregate. The largest reported holder was Essex Woodlands Management, with 13.0 million shares worth $122.9 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Essex Woodlands Management | 13,021,324 | $123M | Unchanged |
| Juniper Investment Company | 6,939,357 | $66M | Unchanged |
| Nantahala Capital Management | 6,000,279 | $57M | Reduced 1.99% |
| BlackRock | 3,435,914 | $32M | Added 9.65% |
| Vanguard | 3,222,429 | $30M | Added 3.74% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BVS?
Bioventus Inc. Class A Common Stock (BVS) is listed on Nasdaq, where it has traded since February 11, 2021.
Who are the largest institutional holders of BVS?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of BVS were Essex Woodlands Management, Juniper Investment Company and Nantahala Capital Management.
How many institutions own BVS?
151 institutions reported a position in BVS for the quarter ended June 30, 2026, worth $509.1 million in total.
Did institutions buy or sell BVS last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for BVS.
Every reported institutional holder, plus insider and congressional trades in BVS, on SentiSense.